Home / HRTX : NASDAQ

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does HRTX make money? Does HRTX have pricing power? What's the Earnings Whisper? Will HRTX profit more as the business scales? What is HRTX's management track record? Is HRTX's current price justified?

Heron Therapeutics, Inc.

$0.32 -$0.94 (-74.98%)

NASDAQ · 14 Sep 2026 20:00 UTC

Previous Close

$0.32

Day Range

$0.31$0.32

Year Range

$0.3$1.58

Market Cap

59.68M

AVG Volume

3.13M

Trailing/Forward PE

-1.68/-

PEG ratio

0.11

Dividend Yield

Next Earnings Date

2026-11-03

Primary Exchange

NASDAQ

Revenue (USD)

HRTX Revenue (USD) by quarter
Period	Revenue (USD)
26 Q2	37.67M
26 Q1	34.71M
25 Q4	40.59M
25 Q3	38.21M
25 Q2	37.2M
25 Q1	38.9M
24 Q4	40.78M
24 Q3	32.81M
24 Q2	36.02M
24 Q1	34.67M

Net Income (USD)

HRTX Net Income (USD) by quarter
Period	Net Income (USD)
26 Q2	-5.49M
26 Q1	-8.11M
25 Q4	-2.95M
25 Q3	-17.5M
25 Q2	-2.38M
25 Q1	2.63M
24 Q4	3.66M
24 Q3	-4.85M
24 Q2	-9.23M
24 Q1	-3.16M

Operating Income (USD)

HRTX Operating Income (USD) by quarter
Period	Operating Income (USD)
26 Q2	-2.04M
26 Q1	-4.76M
25 Q4	38K
25 Q3	-4.09M
25 Q2	-1.64M
25 Q1	3.15M
24 Q4	4.17M
24 Q3	-4.46M
24 Q2	-6.45M
24 Q1	-4.8M

EBITDA (USD)

HRTX EBITDA (USD) by quarter
Period	EBITDA (USD)
26 Q2	-5.49M
26 Q1	-7.58M
25 Q4	-792K
25 Q3	-13.98M
25 Q2	-1.77M
25 Q1	3.69M
24 Q4	8.73M
24 Q3	-3.77M
24 Q2	-8.19M
24 Q1	-1.91M

Cash Flows (USD)

HRTX Cash Flows (USD) by quarter
Period	Cash Flows (USD)
26 Q2	-2.35M
26 Q1	-1.93M
25 Q4	-9.18M
25 Q3	1.33M
25 Q2	-11.08M
25 Q1	-8.98M
24 Q4	-12.42M
24 Q3	2.94M
24 Q2	-5.24M
24 Q1	-9.52M

EPS (USD)

HRTX EPS (USD) by quarter
Period	EPS (USD)
26 Q2	-0.03
26 Q1	-0.04
25 Q4	-0.02
25 Q3	-0.1
25 Q2	-0.02
25 Q1	0.02
24 Q4	0.02
24 Q3	-0.03
24 Q2	-0.06
24 Q1	-0.02

Expenses (USD)

HRTX Expenses (USD) by quarter
Period	Expenses (USD)
26 Q2	28.28M
26 Q1	29.23M
25 Q4	29.43M
25 Q3	30.39M
25 Q2	29.19M
25 Q1	27.4M
24 Q4	27.02M
24 Q3	28.24M
24 Q2	32.59M
24 Q1	31.02M

Cash & Debt (USD)

HRTX Cash & Debt (USD) by quarter
Period	Cash & Debt (USD)
26 Q2	42.66M
26 Q1	44.78M
25 Q4	46.63M
25 Q3	55.49M
25 Q2	40.63M
25 Q1	50.68M
24 Q4	59.28M
24 Q3	70.89M
24 Q2	67.35M
24 Q1	71.52M

Debt ratios

HRTX Debt ratios by quarter
Period	Debt ratios
26 Q2	-3.8
26 Q1	-4.01
25 Q4	-7.31
25 Q3	-25.51
25 Q2	19.77
25 Q1	275.77
24 Q4	-23.07
24 Q3	-5.52
24 Q2	-2.83
24 Q1	-1.48

Margins

HRTX Margins by quarter
Period	Margins
26 Q2	69.28%
26 Q1	69.35%
25 Q4	81.15%
25 Q3	59.74%
25 Q2	73.5%
25 Q1	78.26%
24 Q4	74.92%
24 Q3	71.17%
24 Q2	70.8%
24 Q1	75.64%

Return on Capital

HRTX Return on Capital by quarter
Period	Return on Capital
26 Q2	-79.46%
26 Q1	-88.77%
25 Q4	-20.61%
25 Q3	-117.53%
25 Q2	8.74%
25 Q1	-9.26%
24 Q4	-10.89%
24 Q3	12.12%
24 Q2	24.34%
24 Q1	9.36%

Shares Outstanding

HRTX Shares Outstanding by quarter
Period	Shares Outstanding
26 Q2	190.34M
26 Q1	189.65M
25 Q4	166.71M
25 Q3	170.35M
25 Q2	154.02M
25 Q1	153.49M
24 Q4	153.15M
24 Q3	152.83M
24 Q2	152.31M
24 Q1	151.2M

Book Value Per Share (USD)

HRTX Book Value Per Share (USD) by quarter
Period	Book Value Per Share (USD)
26 Q2	0.04
26 Q1	0.05
25 Q4	0.09
25 Q3	0.09
25 Q2	-0.18
25 Q1	-0.19
24 Q4	-0.22
24 Q3	-0.26
24 Q2	-0.25
24 Q1	-0.22

Total Assets (USD)

HRTX Total Assets (USD) by quarter
Period	Total Assets (USD)
26 Q2	252.26M
26 Q1	246.22M
25 Q4	255.88M
25 Q3	248.95M
25 Q2	232.09M
25 Q1	235.75M
24 Q4	233.15M
24 Q3	220.78M
24 Q2	218.14M
24 Q1	217.89M

Employee Count

HRTX Employee Count by quarter
Period	Employee Count
2025	128
2024	122
2023	126
2022	203
2021	302
2020	223
2019	231
2018	198
2017	145
2016	139

Free Cash Flow Yield

HRTX Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	-20.22%
Sep 26	-20.21%
Sep 26	-18.54%
Aug 26	-19.52%
Aug 26	-20.04%
Aug 26	-18.94%
Aug 26	-22.41%
Jul 26	-22.17%
Jul 26	-24.13%
Jul 26	-23.37%
Jul 26	-26.54%
Jul 26	-25.09%
Jun 26	-25.58%
Jun 26	-26.35%
Jun 26	-27.49%
Jun 26	-25.74%
May 26	-12.64%
May 26	-12.81%
May 26	-12.94%
May 26	-13.84%
May 26	-13.18%
Apr 26	-14.07%
Apr 26	-16.74%
Apr 26	-19.63%
Apr 26	-20.95%
Mar 26	-21.36%
Mar 26	-21.5%
Mar 26	-18.99%
Mar 26	-17.32%
Feb 26	-14.07%
Feb 26	-15.49%
Feb 26	-15.9%
Feb 26	-14.51%
Jan 26	-13.85%
Jan 26	-12.87%
Jan 26	-12.27%
Jan 26	-13.15%
Jan 26	-14.51%
Dec 25	-14.28%
Dec 25	-14.06%
Dec 25	-13.34%
Dec 25	-13.96%
Nov 25	-15.76%
Nov 25	-17.25%
Nov 25	-16.62%
Nov 25	-16.62%
Oct 25	-16.53%
Oct 25	-15.98%
Oct 25	-14.86%
Oct 25	-14.98%
Oct 25	-14.53%
Sep 25	-15.85%
Sep 25	-15.59%
Sep 25	-15.22%
Sep 25	-14.64%
Aug 25	-14.2%
Aug 25	-13.7%
Aug 25	-14.42%
Aug 25	-14.53%
Aug 25	-9.14%
Jul 25	-8.08%
Jul 25	-8%
Jul 25	-7.08%
Jul 25	-7.02%
Jun 25	-7.21%
Jun 25	-7.72%
Jun 25	-8%
Jun 25	-7.35%
May 25	-8.21%
May 25	-8.35%
May 25	-7.84%
May 25	-7.32%
May 25	-6.85%
Apr 25	-6.88%
Apr 25	-8.6%
Apr 25	-8.28%
Apr 25	-7.54%
Mar 25	-7%
Mar 25	-6.65%
Mar 25	-6.82%
Mar 25	-6.62%
Feb 25	-6.41%
Feb 25	-3.64%
Feb 25	-3.53%
Feb 25	-3.61%
Jan 25	-3.7%
Jan 25	-3.44%
Jan 25	-3.86%
Jan 25	-4.06%
Jan 25	-3.79%
Dec 24	-4.06%
Dec 24	-3.98%
Dec 24	-3.93%
Dec 24	-3.88%
Nov 24	-5.29%
Nov 24	-5.88%
Nov 24	-5.29%
Nov 24	-8.45%
Nov 24	-8.31%
Oct 24	-7.99%

Price to Sales

HRTX Price to Sales by quarter
Period	Price to Sales
Sep 26	0.4
Sep 26	0.4
Sep 26	0.43
Aug 26	0.41
Aug 26	0.4
Aug 26	0.42
Aug 26	0.62
Jul 26	0.62
Jul 26	0.57
Jul 26	0.59
Jul 26	0.52
Jul 26	0.55
Jun 26	0.54
Jun 26	0.53
Jun 26	0.5
Jun 26	0.54
May 26	1.09
May 26	1.08
May 26	1.07
May 26	1.3
May 26	1.37
Apr 26	1.28
Apr 26	1.08
Apr 26	0.92
Apr 26	0.86
Mar 26	0.84
Mar 26	0.84
Mar 26	0.95
Mar 26	1.04
Feb 26	1.28
Feb 26	1.3
Feb 26	1.26
Feb 26	1.38
Jan 26	1.45
Jan 26	1.56
Jan 26	1.64
Jan 26	1.53
Jan 26	1.38
Dec 25	1.41
Dec 25	1.43
Dec 25	1.5
Dec 25	1.44
Nov 25	1.27
Nov 25	1.16
Nov 25	1.21
Nov 25	1.21
Oct 25	1.19
Oct 25	1.23
Oct 25	1.33
Oct 25	1.32
Oct 25	1.36
Sep 25	1.24
Sep 25	1.27
Sep 25	1.3
Sep 25	1.35
Aug 25	1.39
Aug 25	1.44
Aug 25	1.37
Aug 25	1.36
Aug 25	1.75
Jul 25	1.97
Jul 25	1.99
Jul 25	2.25
Jul 25	2.27
Jun 25	2.21
Jun 25	2.07
Jun 25	1.99
Jun 25	2.17
May 25	1.94
May 25	1.91
May 25	2.04
May 25	2.18
May 25	2.45
Apr 25	2.44
Apr 25	1.95
Apr 25	2.03
Apr 25	2.23
Mar 25	2.4
Mar 25	2.53
Mar 25	2.46
Mar 25	2.54
Feb 25	2.62
Feb 25	1.92
Feb 25	1.98
Feb 25	1.93
Jan 25	1.89
Jan 25	2.03
Jan 25	1.81
Jan 25	1.72
Jan 25	1.84
Dec 24	1.72
Dec 24	1.75
Dec 24	1.78
Dec 24	1.8
Nov 24	1.32
Nov 24	1.19
Nov 24	1.32
Nov 24	1.95
Nov 24	1.99
Oct 24	2.07

EV/EBITDA

HRTX EV/EBITDA by quarter
Period	EV/EBITDA
Oct 25	45.73
Oct 25	46.63
Oct 25	48.64
Oct 25	48.42
Oct 25	49.31
Sep 25	46.85
Sep 25	47.3
Sep 25	47.97
Sep 25	49.09
Aug 25	49.98
Aug 25	51.1
Aug 25	49.54
Aug 25	49.31
Aug 25	840.9
Jul 25	914.47
Jul 25	921.16
Jul 25	1004.76
Jul 25	1011.45
Jun 25	991.38
Jun 25	944.57
Jun 25	921.16
Jun 25	978.01
May 25	904.44
May 25	894.41
May 25	934.54
May 25	981.35

Price to Book

HRTX Price to Book by quarter
Period	Price to Book
Sep 26	8.69
Sep 26	8.69
Sep 26	9.48
Aug 26	9
Aug 26	8.77
Aug 26	9.28
Aug 26	10.19
Jul 26	10.3
Jul 26	9.46
Jul 26	9.77
Jul 26	8.6
Jul 26	9.1
Jun 26	8.93
Jun 26	8.67
Jun 26	8.3
Jun 26	8.87
May 26	18.06
May 26	17.83
May 26	17.64
May 26	14.07
May 26	14.77
Apr 26	13.84
Apr 26	11.63
Apr 26	9.92
Apr 26	9.3
Mar 26	9.12
Mar 26	9.06
Mar 26	10.26
Mar 26	11.24
Feb 26	13.84
Feb 26	13.5
Feb 26	13.16
Feb 26	14.42
Jan 26	15.11
Jan 26	16.25
Jan 26	17.05
Jan 26	15.91
Jan 26	14.42
Dec 25	14.65
Dec 25	14.88
Dec 25	15.68
Dec 25	14.99
Nov 25	13.28
Nov 25	12.13
Nov 25	12.59
Nov 25	12.59
May 23	21.69
Apr 23	20.98
Apr 23	24.23
Apr 23	23.97
Apr 23	20.02
Mar 23	13.26
Mar 23	9.48
Mar 23	11.55
Mar 23	10.75
Mar 23	11.9
Feb 23	11.35
Feb 23	13.44
Feb 23	13.09
Feb 23	14.13
Jan 23	13.89
Jan 23	14.68
Jan 23	15.78
Jan 23	12.54
Dec 22	12.44
Dec 22	12.79
Dec 22	13.64
Dec 22	13.34
Dec 22	13.74
Nov 22	14.28
Nov 22	14.73
Nov 22	17.12
Aug 22	13.73
Jul 22	11.85
Jul 22	11.64
Jul 22	12.53
Jul 22	14.11
Jul 22	11.59
Jun 22	14.49
Jun 22	11.81
Jun 22	9.85
Jun 22	12.79
May 22	14.32
May 22	15.35
May 22	15.3
May 22	5.4
Apr 22	5.94
Apr 22	6.78
Apr 22	7.72
Apr 22	7.66
Apr 22	7.95
Mar 22	7.23
Mar 22	7.23
Mar 22	6.52
Mar 22	6.98
Feb 22	6.47
Feb 22	6.34
Feb 22	7.52
Feb 22	7.32
Jan 22	6.99

No video analysis for this stock yet. Request one from our team.

News: HRTX

seekingalpha.com · 10 Aug 2026

Heron Therapeutics, Inc. (HRTX) Q2 2026 Earnings Call Transcript

zacks.com · 10 Aug 2026

Heron Therapeutics (HRTX) Reports Q2 Loss, Lags Revenue Estimates

Heron Therapeutics (HRTX) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to a loss of $0.02 per share a year ago.

marketbeat.com · 10 Aug 2026

Heron Therapeutics Q2 Earnings Call Highlights

Heron Therapeutics NASDAQ: HRTX reported second-quarter net revenue of $37.7 million, up from $34.7 million in the first quarter and $37.2 million in the comparable prior-year period, while management said sales of its key products came in below its internal expectations.

globenewswire.com · 27 Jul 2026

Heron Therapeutics to Report Second Quarter 2026 Financial Results on Monday, August 10, 2026

CARY, N.C., July 27, 2026 (GLOBE NEWSWIRE) -- Heron Therapeutics, Inc. (Nasdaq: HRTX) (“Heron” or the “Company”), a commercial-stage biotechnology company, today announced that the Company will host a conference call and live webcast on Monday, August 10, 2026, at 8:30 a.m. ET to report second quarter financial results and discuss recent business highlights.

zacks.com · 15 Jul 2026

New Strong Sell Stocks for July 15th

BV, RAIL and HRTX have been added to the Zacks Rank #5 (Strong Sell) List on July 15th, 2026.